Mohammad Altememi: Artificial Intelligence and Machine Learning in Thrombosis and Hemostasis
Mohammad Altememi, Acting Senior Scientist at NSW Health Pathology, shared an article on LinkedIn:
“Happy to share this publication on AI-ML in Thrombosis and Haemostasis.
This paper highlights the current limitations of AI and ML applications in T and H, while outlining key requirements and future directions needed to advance this rapidly evolving field.
A big thank you to my supervisory team
Prof. Emmanuel Favaloro, Prof. Abishek, Santhakumar and Prof. Md Zahidul, Islam.
Truely leaders in the field, for their contribution guidance,support and mentorship!
Hopefully the first of many publications to come.”
Title: Artificial intelligence and machine learning in thrombosis and hemostasis: a scoping review of clinical and laboratory applications, challenges, and future directions
Authors: Mohammad A. Altememi, Emmanuel J. Favaloro, Md Zahid Islam and Abishek. B. Santhakumar
Read full article here.
Get the latest insights with Hemostasis Today.
-
Apr 12, 2026, 16:36Piotr Czempik: Patient Blood Management Means Safer Care, Better Quality, and Responsible Resource Use
-
Apr 12, 2026, 16:31Eishi Asano: Available Evidence and Unmet Needs in EEG Use During Stroke Management
-
Apr 12, 2026, 16:23Jack Shuang Hou: CorTec Wins 1st-Ever FDA Breakthrough Device Designation for BCI in Stroke Motor Rehabilitation
-
Apr 12, 2026, 15:54Ralf Illing: Proud to Contribute My Patient Voice to OCEANIC-STROKE Research
-
Apr 12, 2026, 15:38Hugo Antonio Romo Rubio: ASH ISTH 2026 Guidelines on Prophylactic Anticoagulation In Pediatrics
-
Apr 12, 2026, 15:26Melissa Lewellyn: The DVT and PE Awareness Resolution from NBCA Is Now Live
-
Apr 12, 2026, 14:58Akram Shibani: HI-PEITHO Trial Reminds Us Why Composite Endpoints Deserve Careful Scrutiny
-
Apr 12, 2026, 14:493 Days, 14 Leaders, 1 Mission at The 13th EHC Youth Leadership Workshop
-
Apr 12, 2026, 14:27Moustafa Abdou: Paroxysmal Nocturnal Hemoglobinuria From a Rare Disease to a Treatable Condition